NL8104938A - 1.1-dioxopenicillanoyloxymethyl-6-(d-alfa-amino-alfa-fenylaceetamido)penicillanaat, werkwijze voor de bereiding en toepassing daarvan. - Google Patents
1.1-dioxopenicillanoyloxymethyl-6-(d-alfa-amino-alfa-fenylaceetamido)penicillanaat, werkwijze voor de bereiding en toepassing daarvan. Download PDFInfo
- Publication number
- NL8104938A NL8104938A NL8104938A NL8104938A NL8104938A NL 8104938 A NL8104938 A NL 8104938A NL 8104938 A NL8104938 A NL 8104938A NL 8104938 A NL8104938 A NL 8104938A NL 8104938 A NL8104938 A NL 8104938A
- Authority
- NL
- Netherlands
- Prior art keywords
- tosylate
- compound
- preparation
- amino
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8035156 | 1980-10-31 | ||
GB8035156 | 1980-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8104938A true NL8104938A (nl) | 1982-05-17 |
Family
ID=10517019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8104938A NL8104938A (nl) | 1980-10-31 | 1981-10-30 | 1.1-dioxopenicillanoyloxymethyl-6-(d-alfa-amino-alfa-fenylaceetamido)penicillanaat, werkwijze voor de bereiding en toepassing daarvan. |
Country Status (26)
Country | Link |
---|---|
US (1) | US4831025A (fr) |
JP (1) | JPS57126493A (fr) |
KR (1) | KR870001982B1 (fr) |
AT (1) | AT373893B (fr) |
AU (1) | AU543870B2 (fr) |
BE (1) | BE890938A (fr) |
CA (1) | CA1180696A (fr) |
CH (1) | CH647527A5 (fr) |
DE (1) | DE3143219A1 (fr) |
DK (1) | DK154219C (fr) |
ES (1) | ES8206531A1 (fr) |
FI (1) | FI813331L (fr) |
FR (1) | FR2493322B1 (fr) |
GB (1) | GB2114969B (fr) |
GR (1) | GR75369B (fr) |
IE (1) | IE51640B1 (fr) |
IL (1) | IL64009A (fr) |
IT (1) | IT1193735B (fr) |
LU (1) | LU83727A1 (fr) |
NL (1) | NL8104938A (fr) |
NO (1) | NO813683L (fr) |
NZ (1) | NZ198622A (fr) |
PH (1) | PH17820A (fr) |
PT (1) | PT73913B (fr) |
SE (1) | SE452322B (fr) |
ZA (1) | ZA817091B (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4432987A (en) * | 1982-04-23 | 1984-02-21 | Pfizer Inc. | Crystalline benzenesulfonate salts of sultamicillin |
PH20068A (en) * | 1982-12-06 | 1986-09-18 | Pfizer | Process and intermediates for sultamicillin and analogs |
KR910009271B1 (ko) * | 1989-06-20 | 1991-11-08 | 김영설 | 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염 |
ES2161602B1 (es) * | 1999-04-08 | 2003-02-16 | Asturpharma S A | Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina. |
US6667042B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Fluroquinilone antibiotic product, use and formulation thereof |
US6610328B2 (en) | 2000-02-24 | 2003-08-26 | Advancis Pharmaceutical Corp. | Amoxicillin-clarithromycin antibiotic composition |
US6991807B2 (en) * | 2000-02-24 | 2006-01-31 | Advancis Pharmaceutical, Corp. | Antibiotic composition |
US6623758B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Cephalosporin-metronidazole antibiotic composition |
US6663890B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Metronidazole antibiotic product, use and formulation thereof |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6663891B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Erythromyacin antibiotic product, use and formulation thereof |
US6632453B2 (en) | 2000-02-24 | 2003-10-14 | Advancis Pharmaceutical Corp. | Ciprofoxacin-metronidazole antibiotic composition |
US6669948B2 (en) | 2000-02-24 | 2003-12-30 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6667057B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Levofloxacin antibiotic product, use and formulation thereof |
CA2400784C (fr) * | 2000-02-24 | 2009-05-19 | Advanced Pharma, Inc. | Produit therapeutique, son application et sa formulation |
US6730320B2 (en) | 2000-02-24 | 2004-05-04 | Advancis Pharmaceutical Corp. | Tetracycline antibiotic product, use and formulation thereof |
US7025989B2 (en) * | 2000-02-24 | 2006-04-11 | Advancis Pharmaceutical Corp. | Multiple-delayed released antibiotic product, use and formulation thereof |
US6627222B2 (en) | 2000-02-24 | 2003-09-30 | Advancis Pharmaceutical Corp. | Amoxicillin-dicloxacillin antibiotic composition |
WO2001062195A1 (fr) * | 2000-02-24 | 2001-08-30 | Advancis Pharmaceutical Corporation | Compositions antibiotiques et antifongiques |
US6638532B2 (en) | 2000-02-24 | 2003-10-28 | Advancis Pharmaceutical Corp. | Tetracycline—doxycycline antibiotic composition |
US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US7105174B2 (en) * | 2000-10-13 | 2006-09-12 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-neoplastic product, use and formulation thereof |
US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
US7157095B2 (en) * | 2000-10-13 | 2007-01-02 | Advancis Pharmaceutical Corporation | Multiple-delayed release antifungal product, use and formulation thereof |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
US20040114368A1 (en) * | 2002-12-13 | 2004-06-17 | Shyu Shing Jy | Light device having rotatable or movable view |
WO2004104022A2 (fr) * | 2003-05-16 | 2004-12-02 | The General Hospital Corporation | Compositions contenant un facteur chimio-tactique epithelial pathogene (eicosanoide et hepoxiline a3), leurs inhibiteurs et leurs procedes d'utilisation |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
JP2006528185A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
JP2006528190A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
CA2535177A1 (fr) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Pastille robuste |
CA2535398C (fr) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotique, utilisation et formulation associees |
AU2004270170B2 (en) | 2003-08-29 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005027877A1 (fr) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotique, son utilisation et sa formulation |
JP2008505124A (ja) | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
WO2007004239A1 (fr) * | 2005-07-06 | 2007-01-11 | Morepen Laboratories Limited | Nouvelle forme polymorphique du tosylate de sultamicilline et procede correspondant |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
WO2014014364A1 (fr) | 2012-07-17 | 2014-01-23 | Bayer New Zealand Limited | Formulations antibiotiques injectables et leurs procédés d'utilisation |
MY172561A (en) | 2012-07-17 | 2019-12-03 | Bayer New Zealand Ltd | Injectable antibiotic formulations and their methods of use |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1532222A (fr) * | 1963-10-28 | 1968-07-12 | Bristol Myers Co | Procédé de préparation de dérivés de la pénicilline |
KR830001903B1 (ko) * | 1979-02-13 | 1983-09-19 | 레오 파마슈티칼 프로덕츠 리미티드 | 페니실란산유도체의 제조방법 |
IE49880B1 (en) * | 1979-02-13 | 1986-01-08 | Leo Pharm Prod Ltd | Penicillin derivatives |
US4244951A (en) * | 1979-05-16 | 1981-01-13 | Pfizer Inc. | Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide |
IE51516B1 (en) * | 1980-10-06 | 1987-01-07 | Leo Pharm Prod Ltd | 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate |
-
1981
- 1981-10-06 IL IL64009A patent/IL64009A/xx not_active IP Right Cessation
- 1981-10-08 IE IE2361/81A patent/IE51640B1/en not_active IP Right Cessation
- 1981-10-13 NZ NZ198622A patent/NZ198622A/en unknown
- 1981-10-14 ZA ZA817091A patent/ZA817091B/xx unknown
- 1981-10-14 GB GB08131010A patent/GB2114969B/en not_active Expired
- 1981-10-15 AU AU76365/81A patent/AU543870B2/en not_active Expired
- 1981-10-19 PH PH26362A patent/PH17820A/en unknown
- 1981-10-20 AT AT0447781A patent/AT373893B/de not_active IP Right Cessation
- 1981-10-23 FI FI813331A patent/FI813331L/fi not_active Application Discontinuation
- 1981-10-23 IT IT68383/81A patent/IT1193735B/it active
- 1981-10-26 CA CA000388756A patent/CA1180696A/fr not_active Expired
- 1981-10-27 DK DK472181A patent/DK154219C/da not_active IP Right Cessation
- 1981-10-29 GR GR66381A patent/GR75369B/el unknown
- 1981-10-29 SE SE8106404A patent/SE452322B/sv not_active IP Right Cessation
- 1981-10-30 CH CH6947/81A patent/CH647527A5/de not_active IP Right Cessation
- 1981-10-30 ES ES506751A patent/ES8206531A1/es not_active Expired
- 1981-10-30 KR KR1019810004171A patent/KR870001982B1/ko active
- 1981-10-30 PT PT73913A patent/PT73913B/pt unknown
- 1981-10-30 JP JP56175559A patent/JPS57126493A/ja active Granted
- 1981-10-30 NL NL8104938A patent/NL8104938A/nl active Search and Examination
- 1981-10-30 LU LU83727A patent/LU83727A1/fr unknown
- 1981-10-30 DE DE19813143219 patent/DE3143219A1/de active Granted
- 1981-10-30 FR FR8120476A patent/FR2493322B1/fr not_active Expired
- 1981-10-30 NO NO813683A patent/NO813683L/no unknown
- 1981-10-30 BE BE0/206403A patent/BE890938A/fr not_active IP Right Cessation
-
1987
- 1987-03-13 US US07/024,858 patent/US4831025A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL8104938A (nl) | 1.1-dioxopenicillanoyloxymethyl-6-(d-alfa-amino-alfa-fenylaceetamido)penicillanaat, werkwijze voor de bereiding en toepassing daarvan. | |
AU752877B2 (en) | Novel crystalline forms of an antiviral benzimidazole compound | |
KR930002509B1 (ko) | 결정성 칼슘 슈도모네이트 제법 | |
HU190603B (en) | Process for the production of /6r7r/-3-carbomoil-oxy-methyl-7- /1z/-2-2/fur-2-il/methoxy-imino-acet-amido/-cef-3-em-4-carboxylic acid-ester of new form | |
HU206348B (en) | Process for producing cristalline beta-lactame-hydrate and pharmaceutical compositions containing them | |
DE3139554C2 (fr) | ||
US3822256A (en) | Crystalline monohydrates of sodium and potassium cephalexin | |
JPS5962584A (ja) | コクシジユ−ム症に対して活性なキナゾリノン誘導体 | |
EP0162394A2 (fr) | Céphalosporines et procédé pour leur préparation | |
NL8200607A (nl) | 2-amino-3(halogeenbenzoyl)-methylfenylazijnzuren, en zouten daarvan. | |
GB2084572A (en) | 1,1-Dioxopenicillanoyloxymethyl 6-(D- alpha -amino- alpha -phenylacetamido)penicillanate napsylate | |
DE69122462T2 (de) | 5-Amino-substituierte Adenosinanaloga als Immunsuppressiva | |
AU631960B2 (en) | Crystalline hydrochloride of new beta-lactam antibiotic and process therefor | |
US3956279A (en) | Crystalline pivaloyloxymethyl d(-)-α-aminobenzylpenicillinate | |
JPH0414679B2 (fr) | ||
US3928591A (en) | 7-(D-{60 -amino-1,4-cyclohexadien-1-ylacetamido)desacetoxycephalosporanic acid dihydrate compositions | |
JPS6145625B2 (fr) | ||
WO2008050871A1 (fr) | Composés de carbapénème cristallin | |
PL80147B1 (en) | Zinc complexes of quaternary pyridine derivatives[gb1219998a] | |
DE1904585B2 (de) | Ester der 7-(alpha-amino-alpha- phenylacetamido)-cephalosporansaeure und ihre herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
BN | A decision not to publish the application has become irrevocable |